![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Prevalence (15%) and incidence of delta hepatitis in HIV-HBV coinfected patients in the Dat'AIDS (French) cohort
|
|
|
Conclusion: HDV coinfection is common in HIV-HBV coinfected patients in France. Most HDV infections are prevalent infections, but some incident infections occurred during follow-up indicating that HDV transmission is still present in this population. Patients born in Africa or in Eastern Europe, IVDU and HBV-HCV coinfected patients are high-risk populations for HDV infection and should be targeted for systematic screening.
Among HIV-HBV coinfected patients, HDV prevalence rate reached 56.5% in IV drug users (IVDU), 38.2% in patients from Eastern Europe and 42.4% in patients coinfected with HCV.
![0705231](../images/070523/070523-16/0705231.gif)
![0705232](../images/070523/070523-16/0705232.gif)
![0705233](../images/070523/070523-16/0705233.gif)
![0705234](../images/070523/070523-16/0705234.gif)
![0705235](../images/070523/070523-16/0705235.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|